Evaluasi Potentially Inappropriate Medication (PIM) Pada Pasien Geriatri Hipertensi Urgensi Menggunakan Metode Beers Di Rawat Inap Rsud Daha Husada

Evaluation of Potentially Inappropriate Medication (PIM) in Geriatric Patients with Hypertensive Urgency Using the Beers Criteria Method in the Inpatient Ward of Daha Husada Regional General Hospital

Authors

  • Fendy Prasetyawan Universitas Kadiri Author
  • Yuneka Saristiana Universitas Kadiri Author
  • Lilik Koernia Wahidah Prodi Farmasi, Fakultas MIPA, Universitas Tulang Bawang Author
  • Asih Widiyastuti Prodi Farmasi, Fakultas MIPA, Universitas Tulang Bawang Author
  • Lisa Savitri Universitas Kadiri Author
  • Novynanda Salmasfattah Universitas Kadiri Author
  • Herman Herman Universitas Kadiri Author
  • Mohammad Firdaus Alshol Universitas Kadiri Author

DOI:

https://doi.org/10.30872/

Keywords:

Geriatri; Hipertensi; Polypharmacy; BeersCriteria; PIM

Abstract

Hipertensi urgensi pada pasien geriatri memerlukan terapi kompleks yang berpotensi meningkatkan kejadian Potentially Inappropriate Medication (PIM). Penelitian ini bertujuan untuk mengevaluasi kejadian Potentially Inappropriate Medication (PIM) pada pasien geriatri hipertensi urgensi menggunakan metode Beers Criteria di rawat inap RSUD Daha Husada. Penelitian ini merupakan penelitian observasional non-eksperimental dengan pendekatan deskriptif retrospektif. Data diperoleh dari rekam medis pasien geriatri dengan diagnosis hipertensi urgensi selama periode penelitian bulan Maret 2026. Teknik pengambilan sampel menggunakan total sampling dan diperoleh sebanyak 103 pasien yang memenuhi kriteria inklusi. Evaluasi PIM dilakukan menggunakan Beers Criteria berdasarkan jenis obat, jumlah obat, polypharmacy, dan potensi interaksi obat. Hasil penelitian menunjukkan mayoritas pasien berjenis kelamin perempuan sebanyak 64 pasien (62,1%) dengan kelompok usia terbanyak 60–69 tahun sebanyak 41 pasien (39,8%). Penyakit penyerta terbanyak adalah diabetes melitus sebanyak 32 pasien (31,1%). Sebagian besar pasien menggunakan 5–8 obat sebanyak 53 pasien (51,5%) dan mengalami polypharmacy. Kejadian PIM ditemukan pada 67 pasien (65%). Jenis obat yang paling banyak termasuk kategori PIM adalah NSAID sebanyak 19 kasus (28,4%), diikuti benzodiazepin sebanyak 14 kasus (20,9%). Interaksi obat kategori moderate merupakan interaksi terbanyak sebanyak 39 pasien (37,9%). Penelitian ini menunjukkan bahwa polypharmacy memiliki hubungan dengan meningkatnya kejadian PIM pada pasien geriatri hipertensi urgensi.

References

[1.] Chen, Y., & Wang, X. (2024). Demographic Shifts And The Rising Prevalence Of Hypertension In Geriatric Patients. The Journal Of Clinical Hypertension, 26(2), 210-218.

[2.] Martin, S. S., Aday, A. W., & Almarzooq, Z. I. (2024). Heart Disease And Stroke Statistics—2024 Update: A Report From The American Heart Association. Circulation, 149(8), E347-E913.

[3.] Rochon, P. A., & Gurwitz, J. H. (2024). Pharmacological Management Of Hypertension In Older Adults: Navigating Pharmacokinetic And Pharmacodynamic Changes. Drugs & Aging, 41(4), 305-319.

[4.] Visseren, F. L. J., & Mach, F. (2024). Global Burden Of Hypertension And Cardiovascular Disease In The Aging Population. European Heart Journal, 45(12), 1023-1035.

[5.] Colosimo, M., & Thomas, R. (2025). Polypharmacy In The Management Of Cardiovascular Comorbidities: Heart Failure And Stroke In Older Patients. Age And Ageing, 54(2), 112-124.

[6.] Davies, L. E., & Kingston, P. (2024). Age-Related Physiological Changes And Their Impact On The Pharmacokinetics And Pharmacodynamics Of Cardiovascular Drugs. Clinical Pharmacokinetics, 63(1), 15-29.

[7.] Formica, D., Rossi, R., & Campi, S. (2025). Polypharmacy, Altered Receptor Sensitivity, And The Risk Of Adverse Drug Events In The Geriatric Population. European Journal Of Clinical Pharmacology, 81(1), 45-56.

[8.] Kjeldsen, S. E., & Narkiewicz, K. (2024). The Intersection Of Hypertension, Diabetes, And Chronic Kidney Disease In The Elderly. Journal Of Hypertension, 42(3), 388-398.

[9.] Mangoni, A. A., & O'Mahony, D. (2024). Adverse Drug Reactions And Inappropriate Prescribing In Older Adults: A Focus On Renal And Hepatic Impairment. Drugs & Aging, 41(2), 115-130.

[10.] Vilela, P., & Rodriguez, M. (2024). Management Of Hypertensive Urgencies And Emergencies In Older Adults: Balancing Efficacy And Safety. American Journal Of Hypertension, 37(5), 412-422.

[11.] Wauters, M., & Petrovic, M. (2024). Deprescribing And Polypharmacy Management In Frail Older Adults With Complex Cardiovascular Diseases. European Journal Of Pharmaceutical Sciences, 194, 106654.

[12.] Alhawassi, T. M., & Krass, I. (2024). Impact Of Polypharmacy On Drug-Related Problems And Potentially Inappropriate Medications In Older Adults. Journal Of Clinical Pharmacy And Therapeutics, 49(2), 150-162.

[13.] Prasetyawan, F., Saristiana, Y., Savitri, L., Salmasfattah, N., Ilmis, T., & Herman, H. (2025). Evaluation Of Rational Antibiotic Use (RAU) In Cerebrovascular Accident (CVA) Patients In The ICU Using The Gyssens Criteria. Pharmacology, Medical Reports, Orthopedic, And Illness Details (COMORBID), 4(3), 173–186.

[14.] Gallagher, P., & O'Mahony, D. (2024). Defining Potentially Inappropriate Prescribing In Older Adults: Balancing Risks, Benefits, And Therapeutic Alternatives. Drugs & Aging, 41(5), 401-415.

[15.] Kim, J. H., & Lee, S. Y. (2024). Potentially Inappropriate Medications And The Risk Of Cognitive Decline In Older Adults: A Systematic Review. Journal Of The American Medical Directors Association, 25(4), 512-520.

[16.] Muhlack, D. C., & Hoppe, J. E. (2024). Prevalence Of Potentially Inappropriate Medication Use Among Hospitalized Older Patients With Multimorbidity And Polypharmacy. BMC Geriatrics, 24(1), 210-222.

[17.] Salvi, F., & Morandi, A. (2025). Adverse Clinical Outcomes Associated With Potentially Inappropriate Medications In Frail Older Adults: Falls, Delirium, And Mortality. Geriatrics & Gerontology International, 25(1), 44-53.

[18.] Oktadiana, I., Daulay, M., Mildawati, R., Prasetyawan, F., Saristiana, Y., & Nugroho, B. P. (2024). Penyuluhan Dan Sosialisasi Tanaman Obat Keluarga Untuk Menurunkan Kadar Gula Darah Di Desa Batu Dua Kabupaten Simalungun. Abdi Masyarakat Vokasi, 1(1), 73-79.

[19.] Dalleur, O., & Spinewine, A. (2024). Multimorbidity And Extensive Polypharmacy As Primary Drivers Of Potentially Inappropriate Medication Use In Hospitalized Older Adults. Journal Of Geriatric Pharmacotherapy, 12(1), 78-89.

[20.] Fick, D. M., & Semla, T. P. (2024). The American Geriatrics Society Beers Criteria: Global Impact On Medication Safety And Evaluating Prescription Quality In Older Adults. Journal Of The American Geriatrics Society, 72(1), 12-18.Lund, B. C., & Steinman, M. A. (2024). Evaluating The Diagnostic Sensitivity Of The Beers Criteria In Detecting Potentially Inappropriate Medications In Geriatric Clinical Settings. Gerontology, 70(3), 211-220.

[21.] O'Mahony, D., & Gallagher, P. (2025). High-Risk Potentially Inappropriate Medications In Older Adults: A Focus On Benzodiazepines, Nsaids, And Anticholinergics. Drugs & Aging, 42(1), 55-68.

[22.] Rochon, P. A., & Petrovic, M. (2024). Age-Related Changes In Pharmacodynamics: Increased Sensitivity And Adverse Clinical Outcomes From Potentially Inappropriate Medications. Age And Ageing, 53(4), 188-199.

[23.] Steinman, M. A., & Fick, D. M. (2024). Clinical Application Of The Updated American Geriatrics Society Beers Criteria For Potentially Inappropriate Medication Use In Older Adults. Journal Of The American Geriatrics Society, 72(2), 345-353.

[24.] Bacchi, S., & Palumbo, P. (2024). The Impact Of Non-Steroidal Anti-Inflammatory Drugs On Renal Function And Blood Pressure In Older Adults With Hypertension. Journal Of Clinical Hypertension, 26(1), 88-97.

[25.] Corsonello, A., & Lattanzio, F. (2025). Therapeutic Complexity In Hospitalized Older Adults: Managing Cardiovascular Comorbidities Alongside Analgesics, Sedatives, And Antiplatelets. Drugs & Aging, 42(3), 205-219.

[26.] Garfinkel, D., & Mangoni, A. A. (2024). Geriatric Physiology And The Risks Of Polypharmacy: Navigating Drug Interactions And Potentially Inappropriate Medications. European Journal Of Clinical Pharmacology, 80(4), 511-523.

[27.] Salvi, F., & Morandi, A. (2024). Benzodiazepine Use In The Geriatric Population: Increased Risks Of Falls, Cognitive Impairment, And Delirium. Geriatrics & Gerontology International, 24(6), 530-541.

[28.] Steinman, M. A., & Fick, D. M. (2025). Ensuring Therapeutic Safety And Effectiveness In Geriatric Patients: The Imperative Of Evaluating Medication Appropriateness. Journal Of The American Geriatrics Society, 73(1), 45-56.

[29.] Varon, J., & Marik, P. E. (2024). Management Of Hypertensive Urgency And Emergency: Achieving Safe Blood Pressure Control With Combination Therapies. American Journal Of Cardiovascular Drugs, 24(2), 145-158.

[30.] Nugroho, B., & Yuliastuti, D. (2024). Application Of The Beers Criteria In Evaluating Medication Safety For Geriatric Patients In Indonesian Healthcare Settings: A Multicenter Study. Asian Journal Of Pharmaceutical And Clinical Research, 17(5), 90-98.

[31.] Wulansari, A., Wiedyaningsih, C., & Probosuseno, P. (2021). Potentially Inappropriate Medication (PIM) Pada Pasien Geriatri Rawat Inap Di RSUD Dr. H. Moch. Ansari Saleh Banjarmasin. Majalah Farmaseutik, 19(1), 91–98.

[32.] Adisaputra, A. D., Yusuf, M. I., & Tandah, M. R. (2022). Identifikasi Potentially Inappropriate Medication (PIM) Berdasarkan Beers Criteria 2019 Pada Pasien Geriatri Di RSUD Undata Provinsi Sulawesi Tengah. Indonesian Journal Of Clinical Pharmacy, 11(2), 120–128.

[33.] Aptika, F., Rahmawati, D., & Nugroho, A. (2025). Analysis Of Potentially Inappropriate Medication (PIM) Risk Factors In Geriatric Hypertensive Patients With Comorbidities During Hospitalization. Edu Science And Pharmacy Journal, 4(1), 45–54.

[34.] Faisal, S., Utami, P., & Rahardjo, B. (2025). Factors Contributing To The Prevalence Of Potential Drug-Drug Interactions Among Hospitalized Older Adults In Indonesia. Medical Journal Of Indonesia, 34(1), 12–20.

[35.] Fathurrahmi, F., Wilar, G., Levita, J., & Winarni, R. (2023). Analysis Of Potentially Inappropriate Prescriptions (PIP) Based On STOPP/START Criteria In Geriatric Patients With Cardiovascular Disorders At Hasan Sadikin Hospital, Bandung, West Java, Indonesia. Pharmacology And Clinical Pharmacy Research, 8(3), 145–154.

[36.] Kementerian Kesehatan Republik Indonesia. (2023). Profil Kesehatan Indonesia 2023. Kementerian Kesehatan RI.

[37.] Mahardika, R., Nurmainah, & Robiyanto. (2022). Hubungan Polypharmacy Terhadap Kejadian Potentially Inappropriate Medication (PIM) Pada Pasien Geriatri Rawat Inap. Jurnal Sains Farmasi & Klinis, 9(2), 134–142.

[38.] American Geriatrics Society. (2023). American Geriatrics Society Updated Beers Criteria® For Potentially Inappropriate Medication Use In Older Adults. Journal Of The American Geriatrics Society, 71(7), 2052–2081.

[39.] Cipolle, R. J., Strand, L. M., & Morley, P. C. (2012). Pharmaceutical Care Practice: The Patient-Centered Approach To Medication Management Services (3rd Ed.). Mcgraw-Hill Education.

[40.] World Health Organization. (2022). Promoting Rational Use Of Medicines: Core Components. World Health Organization.

[41.] Davies, E. A., & O’Mahony, M. S. (2015). Adverse Drug Reactions In Special Populations – The Elderly. British Journal Of Clinical Pharmacology, 80(4), 796–807.

[42.] Aronow, W. S. (2020). Treatment Of Hypertensive Emergencies And Urgencies In Older Adults. Annals Of Translational Medicine, 8(12), 785.

[43.] American Geriatrics Society. (2023). American Geriatrics Society Updated Beers Criteria® For Potentially Inappropriate Medication Use In Older Adults. Journal Of The American Geriatrics Society, 71(7), 2052–2081.

[44.] By The American Geriatrics Society Beers Criteria® Update Expert Panel. (2019). American Geriatrics Society 2019 Updated AGS Beers Criteria® For Potentially Inappropriate Medication Use In Older Adults. Journal Of The American Geriatrics Society, 67(4), 674–694.

[45.] O’Mahony, D., O’Sullivan, D., Byrne, S., O’Connor, M. N., Ryan, C., & Gallagher, P. (2018). STOPP/START Criteria For Potentially Inappropriate Prescribing In Older People: Version 2. Age And Ageing, 44(2), 213–218.

[46.] Motter, F. R., Fritzen, J. S., Hilmer, S. N., Paniz, É. V., & Paniz, V. M. V. (2018). Potentially Inappropriate Medication In The Elderly: A Systematic Review Of Validated Explicit Criteria. European Journal Of Clinical Pharmacology, 74(6), 679–700.

[47.] Maher, R. L., Hanlon, J., & Hajjar, E. R. (2014). Clinical Consequences Of Polypharmacy In Elderly. Expert Opinion On Drug Safety, 13(1), 57–65.

[48.] Rankin, A., Cadogan, C. A., Patterson, S. M., Kerse, N., Cardwell, C. R., Bradley, M. C., & Hughes, C. M. (2018). Interventions To Improve The Appropriate Use Of Polypharmacy For Older People. Cochrane Database Of Systematic Reviews, 9(9), CD008165.

Downloads

Published

2026-05-29

Issue

Vol. 7 No. 2 (2026): J. Sains Kes.

Section

Articles

License

Copyright (c) 2026 Jurnal Sains dan Kesehatan

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


Deprecated: json_decode(): Passing null to parameter #1 ($json) of type string is deprecated in /home/jskff/public_html/plugins/generic/citations/CitationsPlugin.php on line 68

How to Cite

[1]
F. Prasetyawan, “Evaluasi Potentially Inappropriate Medication (PIM) Pada Pasien Geriatri Hipertensi Urgensi Menggunakan Metode Beers Di Rawat Inap Rsud Daha Husada: Evaluation of Potentially Inappropriate Medication (PIM) in Geriatric Patients with Hypertensive Urgency Using the Beers Criteria Method in the Inpatient Ward of Daha Husada Regional General Hospital”, J. Sains. Kes, vol. 7, no. 2, pp. 250–264, May 2026, doi: 10.30872/.

Similar Articles

31-40 of 41

You may also start an advanced similarity search for this article.